Trials / Completed
CompletedNCT01174147
A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093)
Brazilian Network of Candidemia: a Laboratory-based Surveillance Study on Candida Bloodstream Infections in 10 Medical Centers
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 436 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the incidence rate of Candida blood stream infection (candidemia) among people hospitalized in participating medical centers in Brazil, and will assess the antifungal drug susceptibility patterns of Candida clinical isolates. No hypotheses will be tested in the study. Candida blood stream isolates collected from people hospitalized for any reason during the study period will be sent to a core mycology laboratory for antifungal drug susceptibility testing. All people who develop candidemia while hospitalized will be considered participants in the study.
Conditions
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2012-11-01
- Completion
- 2012-11-01
- First posted
- 2010-08-03
- Last updated
- 2016-10-13
Source: ClinicalTrials.gov record NCT01174147. Inclusion in this directory is not an endorsement.